The predictive capacity and additional prognostic power of N-terminal pro-B-type natriuretic peptide in Chinese elderly with chronic heart failure

被引:10
|
作者
Fu, Shihui [1 ,2 ,3 ]
Xie, Leixing [2 ,3 ]
Li, Dongyun [1 ,2 ,3 ]
Ye, Ping [1 ]
Luo, Leiming [1 ]
机构
[1] Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Cardiol, Beijing 100853, Peoples R China
[2] Chinese Peoples Liberat Army Gen Hosp, Dept Cardiol, Beijing 100853, Peoples R China
[3] Chinese Peoples Liberat Army Gen Hosp, Hainan Branch, Beijing 100853, Peoples R China
关键词
NT-proBNP; prognosis; chronic heart failure; elderly; IMPACT; GUIDELINES; SURVIVAL;
D O I
10.2147/CIA.S77417
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objective: This study was conducted to research the prognostic utility of N-terminal pro-B-type natriuretic peptide (NT-proBNP), compare the utility of the Seattle Heart Failure Score (SHFS) with NT-proBNP, develop a risk-evaluation model based on NT-proBNP, assess the associations of NT-proBNP with patient characteristics, and screen for decisive factors of NT-proBNP in Chinese elderly with chronic heart failure (CHF). Patients and methods: There were 306 patients (>= 60 years) with CHF chosen as study subjects. Each one received an assessment of NT-proBNP on serum. The end point was all-cause mortality during a mean follow-up period of 471 days. Results: Subjects had a median age of 85 (60-100) years, a median NT-proBNP of 1,743.4 pg/mL, and a median SHFS of 1.87. During the follow-up period, 104 deaths occurred. NT-proBNP was significantly related to mortality (odds ratio 1.603, 95% confidence interval 1.407-1.826; P<0.001) and the significance persisted after full adjustment (odds ratio 1.282, 95% confidence interval 1.103-1.489; P=0.001). Age, New York Heart Association class IV CHF, plasma albumin, and neutrophils/lymphocytes were also independent predictors for mortality (P<0.05 for all). NT-proBNP and the SHFS showed similar predictive capacities (0.736 versus 0.796, P=0.105). The addition of NT-proBNP to the SHFS (0.818 versus 0.796, P=0.168) generated marginal growth in the c-statistic. The model based on NT-proBNP consisting of all selected predictors in this study, including age, New York Heart Association class IV CHF, plasma albumin, neutrophils/lymphocytes, and NT-proBNP, had a moderately higher c-statistic compared with the SHFS (0.846 versus 0.796, P=0.066). NT-proBNP was bound with the SHFS (r=0.500, P<0.001). Characteristics regarding general condition, inflammation, and cardiac and renal function were the decisive factors of NT-proBNP (P<0.05 for all). Conclusion: As a comprehensive representation of the patient characteristics described earlier, NT-proBNP values provided significant prognostic power similar to the SHFS in Chinese elderly with CHF. A novel model based on NT-proBNP could offer help for risk stratification.
引用
收藏
页码:359 / 365
页数:7
相关论文
共 50 条
  • [21] N-Terminal Pro-B-Type Natriuretic Peptide as a Marker of Severity of Heart Failure in Children with Congenital Heart Diseases
    Ritabrata Roy Chowdhury
    Satnam Kaur
    Rani Gera
    Pediatric Cardiology, 2023, 44 : 1716 - 1720
  • [22] N-terminal pro-B-type natriuretic peptide concentrations, testing and associations with worsening heart failure events
    Ferrannini, Giulia
    Benson, Lina
    Lautsch, Dominik
    Dahlstroem, Ulf
    Lund, Lars H.
    Savarese, Gianluigi
    Carrero, Juan Jesus
    ESC HEART FAILURE, 2024, 11 (02): : 759 - 771
  • [23] N-terminal pro-B-type natriuretic peptide: a potential marker of fetal heart failure in hemolytic disease
    Luterek, Katarzyna
    Szymusik, Iwona
    Bartkowiak, Robert
    Koltowski, Lukasz
    Filipiak, Krzysztof J.
    Wielgos, Miroslaw
    NEUROENDOCRINOLOGY LETTERS, 2011, 32 (05) : 657 - 662
  • [24] Comparative Prognostic Value of Plasma and Urinary N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Acute Destabilized Heart Failure
    Manzano-Fernandez, Sergio
    Januzzi, James L.
    Boronat Garcia, Miguel
    Bonaque-Gonzalez, Juan C.
    Munoz-Esparza, Carmen
    Albaladejo-Oton, Maria D.
    Pastor-Perez, Francisco J.
    Pastor, Patricia
    Valdes, Mariano
    Pascual-Figal, Domingo A.
    REVISTA ESPANOLA DE CARDIOLOGIA, 2011, 64 (05): : 365 - 372
  • [25] N-terminal pro-B-type natriuretic peptide in early and advanced phases of obesity
    Mangge, Harald
    Almer, Gunter
    Zelzer, Sieglinde
    Vasan, Ramachandran
    Kraigher-Krainer, Elisabeth
    Gasser, Robert
    Schnedl, Wolfgang
    Ille, Rottraut
    Wallner, Sandra
    Moeller, Reinhard
    Horejsi, Renate
    Weghuber, Daniel
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 (09) : 1539 - 1545
  • [26] Renal Dysfunction and Accuracy of N-Terminal Pro-B-Type Natriuretic Peptide in Predicting Mortality for Hospitalized Patients With Heart Failure
    Scrutinio, Domenico
    Mastropasqua, Filippo
    Guida, Pietro
    Ammirati, Enrico
    Ricci, Vitoantonio
    Raimondo, Rosa
    Frigerio, Maria
    Lagioia, Rocco
    Oliva, Fabrizio
    CIRCULATION JOURNAL, 2014, 78 (10) : 2439 - 2446
  • [27] Pro-A-Type Natriuretic Peptide, Proadrenomedullin, and N-Terminal Pro-B-Type Natriuretic Peptide Used in a Multimarker Strategy in Primary Health Care in Risk Assessment of Patients With Symptoms of Heart Failure
    Alehagen, Urban
    Dahlstrom, Ulf
    Rehfeld, Jens F.
    Goetze, Jens P.
    JOURNAL OF CARDIAC FAILURE, 2013, 19 (01) : 31 - 39
  • [28] Prognostic Significance of the N-Terminal Pro-B-Type Natriuretic Peptide in Lung Transplant Candidates on the Waiting List
    Izhakian, Shimon
    Frajman, Assaf
    Freidkin, Lev
    Shtraichman, Osnat
    Rosengarten, Dror
    Pertzov, Barak
    Barac, Yaron D.
    Kramer, Mordechai Reuven
    DIAGNOSTICS, 2022, 12 (09)
  • [29] The Role of N-Terminal Pro-B-Type Natriuretic Peptide in the Diagnosis of Congestive Heart Failure in Children - Correlation With the Heart Failure Score and Comparison With B-Type Natriuretic Peptide
    Sugimoto, Masaya
    Manabe, Hiromi
    Nakau, Kouichi
    Furuya, Akiko
    Okushima, Kasumi
    Fujiyasu, Hiroaki
    Kakuya, Fujio
    Goh, Kazutomo
    Fujieda, Kenji
    Kajino, Hiroki
    CIRCULATION JOURNAL, 2010, 74 (05) : 998 - 1005
  • [30] Hemodynamic Determinants of the Biologic Variation of N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Stable Systolic Chronic Heart Failure
    Taeger, Tobias
    Wiedergruen, Ann-Kathrin
    Froehlich, Hanna
    Cebola, Rita
    Corletto, Anna
    Horsch, Andrea
    Hess, Georg
    Slottje, Karen
    Zdunek, Dietmar
    Katus, Hugo A.
    Wians, Frank H., Jr.
    Frankenstein, Lutz
    JOURNAL OF CARDIAC FAILURE, 2017, 23 (12) : 835 - 842